Sandbox lung cancer differential

Revision as of 14:32, 21 March 2018 by Anmol Pitliya (talk | contribs)
Jump to navigation Jump to search
  • Differentiation of primary and secondary lung tumors is difficult due to overlapping histologic features.
  • Topography, size and form of pulmonary growth pattern are important aspects for the differential diagnosis.
  • The following table summarizes the differentiation of various lung tumors based on histological and topographical features:[1]
Benign Lung Tumors[2]
Risk/Epidemiology Pleuripotent cells Topography Gross Histology Immunohistochemistry Imaging Metastasis
Papilloma[3] Squamous cell papilloma
  • HPV 6 and 11
  • Men
  • Median age of diagnosis is 54 years
  • Endobronchial
  • Cauliflower-like lesions
  • Tan-white soft to semifirm protrutions
    • Loose fibrovascular core
    • Stratified squamous epithelium
    • Acanthosis
    • Binucleate forms and perinuclear halos
    • Koilocytosis
  • N/A
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Glandular papilloma
  • Rare
  • Mean age of diagnosis is 68 years
  • Endobronchial
  • White to tan endobronchial polyps that measure from 0.7-1.5 cm
  • N/A
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Adenoma[4] Alveolar adenoma
  • Mean age of diagnosis is 53 years
  • Female predominance
  • All lung lobes
  • Lower lobes
  • Hilar
  • 0.7-6.0 cm
  • Well demarcated smooth
  • Lobulated, multicystic
  • Soft to firm
  • Pale yellow to tan cut surfaces
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Papillary adenoma[5]
  • Mean age of diagnosis is 32 years
  • Male predominance
  • Bronchioloalveolar cell
  • No lobar predilection
  • Involves alveolar parenchyma
  • Well defined
  • Encapsulated
  • Soft, spongy to firm mass
  • Granular gray white/ brown
  • 1.0- 4.0 cm
  • Incidental finding
  • N/A
Mucinous cystadenoma
  • No sex predilection
  • Mean age of diagnosis is 52 years
  • Central
  • White-pink to tan
  • Smooth and shiny tumors
  • Gelatinous mucoid solid core
  • 0.7-7.5 cm
  • Numerous mucin-filled cystic spaces
  • Non-dilated microacini, glands, tubules and papillae
  • Coin lesion
  • Air-meniscus sign
  • N/A
Malignant Lung Tumors[6]
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Squamous cell carcinoma[7] Papillary
  • Cigarette smokers
  • Arsenic
  • Central
  • White or grey lesions
  • Focal carbon pigment deposits
  • Cavitations.
  • Intraluminal polypoid masses
  • Infiltration
  • Exophytic
  • Intra-epithelial
  • Without invasion
  • Keratin
  • Cytokeratins
  • CEA
  • Thyroid transcription factor-1 (TTF-1)
  • Lobar or entire lung collapse
  • Shift of the mediastinum to the ipsilateral side.
  • Hilar, perihilar or mediastinal masses
Clear cell
  • Cells with clear cytoplasm
Small cell
  • Poorly differentiated cells
  • Focal squamous
  • No characteristic nuclear features of SCC.
  • Intercellular bridges or keratinization.
Basaloid
  • Peripheral palisading of nuclei.
  • Poor differentiation
Small cell carcinoma[8]
  • Smoking
  • Radon exposure
  • Bronchial precursor cell
  • White-tan, soft, friable perihilar masses.
  • Extensive necrosis.
  • 5% peripheral coin lesions
  • Sheet-like growth
  • Nesting,
  • Trabeculae
  • Peripheral palisading
  • Rosette formation
  • High mitotic rate
  • CD56
  • Chromogranin
  • Synaptophysin
  • TTF-1
  • Hilar or perihilar masses
  • Mediastinal lymphadenopathy
  • Lobar collapse
  • Bone marrow
  • Liver metastases
Adeno carcinoma[9][10][11] Acinar adenocarcinoma
  • Smokers
  • Peripheral
  • Single or multiple lesions
  • Different in size
  • Peripheral distribution.
  • Gray-white central fibrosis
  • Pleural puckering
  • Anthracotic pigmentation.
    • Necrosis,
    • Cavitation
    • Hemorrhage.
  • Lobulated or ill defined edges.
  • Irregular-shaped glands
  • Malignant cells
    • Hyperchromatic nuclei
    • Fibroblastic stroma
  • Epithelial markers (AE1/AE3, CAM 5.2)
  • Carcinoembryonic antigen
  • CK7
  • TTF-1
  • Peripheral nodules under 4.0 cm in size
  • Central location as a hilar or perihilar mass
  • Rarely show cavitations.
  • Hilar adenopathy
  • Adenocarcinomas account for the majority of small peripheral cancers identified radiologically.
Aerogenous spread is characteristic
  • Brain
  • Bone
  • Adrenal glands
  • Liver
Papillary adenocarcinoma
  • Papillae
  • Necrosis
  • Surrounding invasion
  • Cuboidal to columnar epithemlial linning
  • Mucinous or non-mucinous
Bronchio-alveolar carcinoma Non-mucinous
  • Clara cells
  • Type II cells
Mucinous
  • Low grade differentiation
  • Composed of
    • Tall columnar cells
    • Basal nuclei
    • Pale cytoplasm resembling goblet cells
    • Varying amounts of cytoplasmic mucin
  • Cytologic atypia
Mixed non-mucinous and mucinous or indeterminate
Solid adenocarcinoma with mucin production Fetal adenocarcinoma
  • Consists glandular elements
    • Tubules of glycogen-rich
    • Non-ciliated cells
    • Subnuclear and supranuclear glycogen vacuoles
    • Rounded morules of polygonal cells with abundant eosinophilic and finely granular cytoplasm.
Mucinous (“colloid”) carcinoma
  • Dissecting pools of mucin containing neoplastic cells.
Mucinous cystadenocarcinoma
  • Partial fibrous tissue capsule.
  • Central cystic change with mucin pooling
  • Neoplastic mucinous epithelium grows along alveolar walls.
Signet ring adenocarcinoma
Clear cell adenocarcinoma
Large cell carcinoma[12] Basaloid large cell carcinoma of the lung
  • Approximately 10% of lung cancers.
  • Smoking
  • Neuro endocrine cells
  • Suprabasal bronchial cells.
  • Peripheral masses
  • Bronchi
  • Soft, pink-tan tumor
  • Necrosis and occasional hemorrhage
  • Cavitations.
  • Exophytic bronchial growth
  • Invasive growth pattern
  • Peripheral palisading
  • Small, monomorphic, cuboidal fusiform
  • Large, peripheral masses
  • Pleura
  • Liver
  • Bone
  • Brain
  • Abdominal lymph nodes
  • Pericardium
Clear cell carcinoma of the lung
  • Clear cells
Lymphoepithelioma-like carcinoma of the lung
  • Syncytial growth pattern
  • Eosinophilic nucleoli
  • Lymphocytic infiltration
  • Invasive
  • amyloid deposition
Large-cell lung carcinoma with rhabdoid phenotype
  • Eosinophilic cytoplasmic globules
  • Small foci of adenocarcinoma
  • Eosinophilic inclusions
Mixed type
Sarcomatoid carcinoma[13] Carcinosarcoma
  • Accounts for only 0.3-1.3% of all lung malignancies
  • Mean age at diagnosis is 60 years
  • Tobacco smoking
  • Asbestos exposure
  • Undifferentiated epithelial cells
  • Central or peripheral
  • Upper lobes
  • > 5 cm
  • Well circumscribed
  • Grey, yellow or tan creamy, gritty,
  • Mucoid and/or hemorrhagic with significant necrosis.
  • Sessile or pedunculated
  • Infiltrative
  • Biphasic
  • Mixture of carcinomatous and sarcomatous cells
  • Keratin
  • S-100
  • No specific imaging features 
  • Aggressive tumor
  • Esophagus, jejunum, rectum
  • Kidney
Spindle cell carcinoma
  • Only spindle shaped tumor cells
  • Lymphoplasmacytic infiltrates
  • Keratin
  • EMA
  • Cytokeratin
  • Vimentin,
  • CEA
  • TTF-1
Giant cell carcinoma
  • Multi- and/or mononucleated tumor giant cells
Pleomorphic carcinoma
  • Poorly differentiated
  • Mixture of spindle cells and/or giant cells
  • Fibrous or myxoid stroma
Pulmonary blastoma
  • Biphasic
  • Mixture of epithelial and mesenchymal stroma
  • Keratin
  • EMA
  • CEA
  • Chromogranin A
Carcinoid tumor[14] Typical carcinoid

Atypical carcinoid

  • Neuroendocrine cells of lung
  • Typical carcinoids are throughout the lungs
  • AC is more commonly peripheral
  • Firm, well demarcated, tan to yellow tumors.
  • Uniform polygonal cells
  • Nuclear atypia
  • Pleomorphism
  • The most common patterns are the organoid and trabecular
  • Highly vascularized fibrovascular stroma
  • Focal necrosis
  • Cytokeratin
  • Chromogranin
  • Synaptophysin
  • Leu-7 (CD57)
  • N-CAM (CD56)
  • S-100 protein
  • Well defined pulmonary nodules
  • Calcifications is often seen.
  • Intense contrast enhancement.
  • Liver
  • Bone
Salivary gland tumors[15] Mucoepidermoid carcinoma
  • Most patients presents in the third and fourth decade
  • Constitutes of less than 1% tumor
  • No association with cigarette smoking or other risk factors.
  • Primitive cells of tracheobronchial origin
  • Bronchial glands
  • Ranging in size from 0.5-6 cm
  • Soft, polypoid, and pink-tan in colour
  • High-grade lesions are infiltrative
  • Exophytic endobronchial growth
  • Surface epithelium lacking changes of insitu carcinoma
  • Absence of individual cell keratinization
  • Transitional areas to low grade mucoepidermoid carcinoma.
  • Well-circumscribed oval or lobulated mass
  • Calcifications
  • Post-obstructive pneumonic infiltrates
  • Rare
  • Liver
  • Bones
  • Adrenal gland
  • Brain
Adenoid cystic carcinoma
  • Constitutes less than 1% of all lung tumors.
  • Most commonly seen in fourth and fifth decades of life
  • Primitive cells of tracheobronchial origin
  • Trachea
  • Gray-white or tan polypoid lesions.
  • Size ranges from 1–4 cm
  • Infiltrative margins.
  • Invades other cell layers.
  • Heterogeneous cellularity
  • Cribriform pattern
  • Perineural invasion
  • Immunoperoxidase
  • Cytokeratin
  • Vimentin
  • Actin
  • Calponin
  • S-100 protein
  • p63
  • GFAP
  • Liver
  • Brain
  • Bone
  • Spleen
  • Kidney
  • Adrenal glands
Epithelial-myoepithelial carcinoma
  • Age ranges from 33 to 71 years
  • No association between smoking
  • Myoepithelial cells
  • Endobronchia
  • Solid to gelatinous in texture
  • White to gray in colour
  • Myoepithelial cells
  • Dual layer of cells lining ducts.
  • Low mitotic activity.
  • MNF116
  • EMA
  • SMA and S-100
  • Reflects airway obstruction
  • Breast
Preinvasive lesions[16] Squamous carcinoma in situ
  • Most commonly seen in fifth or sixth decades
  • Mostly seen in women
  • Basal cells of squamous epithelium
  • Bronchi
  • Focal or multi-focal plaque-like greyish lesions
  • Nonspecific erythema
  • Even nodular or polypoid lesions
  • Goblet cell hyperplasia
  • Basal cell hyperplasia
  • Squamous dysplasia
  • Angiogenic squamous dysplasia
  • Micropapillomatosis
  • EGFR
  • HER2/neu
  • p53
  • MCM2
  • Ki-67
  • Cytokeratin 5/6
  • bcl-2
  • VEGF
  • Folate binding protein
  • p16
  • Liver
  • Brain
  • Bone
  • Spleen
Atypical adenomatous hyperplasia
  • Surfactant apoprotein
  • Clara cell specific 10kDd protein
  • Pleura
  • Upper lobes
  • Multiple grey to yellow foci
  • 1mm to 10mm in size.
  • Intranuclear inclusions
  • Clara cells and type II pneumocytes.
  • Thickened alveolar walls
  • Discontinuous lining of cells
  • Moderate atypia.
  • Pseudopapillae
  • CEA
  • MMPs
  • E-cadherin,
  • ß-catenin,
  • CD44v6
  • TTF-1
  • TP53
  • Typically not visualized on radiographs.
  • Small non-solid nodules
  • Ground glass opacity
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
  • Pulmonary neuroendocrine cells
  • Endobronchial
  • Early lesions
    • Small, gray-white nodules
    • Resembling ‘miliary bodies’
  • Larger carcinoid tumors are
    • Firm
    • Homogeneous
    • Well-defined
    • Grey or yellow-white masses.
  • Nodular aggregates
  • Fibrosis due to proliferation
  • Invade locally
  • Fibrous stroma aggregates to form ‘tumorlets’.
  • Carcinoids are tumorlets >5cm.
  • Mosaic pattern of air trapping
  • Sometimes with nodules
  • Thickened bronchial and bronchiolar walls
Mesenchymal tumors[17] Epithelioid haemangioendothelioma / Angiosarcoma
  • Caucasian
  • 80% are women.
  • Endothelial cells
  • Intravascular
  • 0.3-2.0 cm circumscribed mass
  • Gray-white or gray-tan firm tissue
  • Yellow flecks
  • Central calcifications
  • Cut surface has a cartilaginous consistency.
  • Round to oval-shaped nodules
    • Central sclerosis
    • Hypocellular zone
    • Peripheral cellular zone
    • Calcifications
    • Intranuclear cytoplasmic inclusions
  • CD31
  • CD34
  • factor VIII (von Willebrand factor)
  • Fli1
  • FKBP12
  • Cytokeratin
  • Multiple
  • Bilateral
  • Small nodules
  • 1-2 cm in size.
  • Can mimic pulmonary Langerhans’ cell histiocytosis.
  • Calcifications
  • Liver
  • Bone
  • Soft tissue
Pleuropulmonary blastoma
  • Most common in children
  • Median age of diagnosis is 2 years.
  • Thoracic splanchnopleural mesenchyme.
  • Pleura
  • Lung
  • Purely cystic
  • Thin-walled
  • Rarely solid
  • Firm to gelatinous
  • Upto 15 cm
  • Type I
    • Purely cystic
    • Lined by respiratory type epithelium
    • Underneath malignant cells
  • Type II
    • Partial or complete overgrowth of the septal stroma
  • Type III
    • Mixed cells
  • Vimentin
  • S-100 protein
  • Unilateral
  • Localized airfilled cysts
  • Septal thickening or an intracystic mass
  • Brain
  • Spinal cord
  • Skeletal system
  • Eyes
  • Pancreas
Chondroma
  • Young women
  • Chondrocytes,
  • Cartilaginous cells
  • Peripheral lesions in lung
  • 1o seen in
    • Stomach
    • Bone
    • Paraganglia
  • Peripheral
  • Solid lesions
  • Calcified
  • Capsulated lobules
  • Hypocellular
  • Features of malignancy are absent
  • N/A
  • Multiple
  • Well circumscribed lesions
  • “Pop-corn” calcifications
  • Benign tumor
Congenital peribronchial myofibroblastic tumor
  • Rare
  • Sporadic
  • Complicated by
    • Polydramnios
    • Non-immune hydrops fetalis
  • Spindle cells
  • 5-10 cm
  • Well-circumscribed
  • Non-encapsulated
  • Smooth or multinodular surface
  • The cut surface has a tann-grey to yellow-tan fleshy appearance.
    • Haemorrhage
    • Necrosis
  • Fascicles of spindle cells.
  • Bronchial invasion
  • Peribronchial distribution
  • Cystic foci of haemorrhage
  • Vimentin
  • Well circumscribed
  • Opacifying the hemithorax
  • Heterogeneous mass
Diffuse pulmonary lymphangiomatosis
  • Children
  • Young adults of both sexes
  • Smooth muscles cells of lymphatic vessels.
  • Along the lymphatic distribution.
  • Prominence of the bronchovascular bundles along
    • Pleura
    • Interlobular pulmonary septa
    • Mediastinum
  • Anastomosing endothelial-lined cells along lymphatic routes.
  • Spindle cells
  • Intra alveolar siderophages
  • FVIIIrAg
  • Vimentin
  • UEA
  • Increased interstitial markings
  • Thickening of the
    • Interlobular septa
    • Fissures
    • Central airways
    • Pleura
Inflammatory myofibroblastic tumor
  • Previous viral infections
  • HHV8
  • Children
  • Myofibroblastic cells
  • Localized to bronchia
  • Solitary
  • Round rubbery masses
  • Yellowish-gray discoloration
  • Average size of 3.0 cm
  • Non encapculated
  • Calcifications
  • No local invasion
  • Mixture of spindle cells
    • Fibroblastic
    • Myofibroblastic
  • Arranged in fascicles
  • Cytologic atypia
  • Touton type giant cells.
  • Plasma cells
  • Lymphoid follicles
  • Vimentin
  • Actin
  • ALK1
  • p80
  • Solitary mass
  • Regular borders
  • Spiculated appearance
  • Accompanied by
    • Post-obstructive pneumonia
    • Atelectasis
  • Rare
Pulmonary artery sarcoma
  • Mean age of diagnosis is 49.3 years
  • Commonly misdiagnosed as PE
  • Mesenchymal cells of the intima
  • Primitive cells of the bulbus cordi in the trunk of pulmonary artery.
  • Pulmonary trunk most commonly
    • Right pulmonary artery
    • Left pulmonary artery
    • Pulmonary valve,
    • Right ventricular outflow tract
  • Mucoid or gelatinous clots filling vascular lumens
  • The cut surface may show
    • Firm fibrotic areas
    • Bony/gritty or chondromyxoid foci
    • Haemorrhage and necrosis are common in high-grade tumors
  • Spindle cells in
    • A myxoid background
    • Collagenized stroma
    • Recanalized thrombi
  • Vimentin
  • Osteopontin
  • Factor VIII
  • CD31
  • CD34
  • Findings overlap with those of chronic thromboembolic disease
  • Decreased vascularity
  • Heterogeneous soft tissue density
  • Smooth vascular tapering
  • Lung
  • Mediastinum
Pulmonary vein sarcoma
  • Most common in women.
  • Mean age of diagnosis is 49.
  • Smooth muscle
  • Pulmonary vein
  • Fleshy-tan tumor
  • Can occlude the lumen of the involved vessel.
  • 3.0- 20.0 cm
  • Invasion of wall of the vein.
  • Smooth muscle differentiation
  • Moderate to highly cellular spindle cell neoplasms
  • Epithelioid morphology
  • Vimentin
  • Desmin and actin
  • Keratin
  • N/A

Differentiation of lung cancer from other diseases with similar presentation

The following table summarizes the differentiation of lung cancer from other disease entities with similar presentation.[18][19][20][21][22]

Disease Clinical features

Signs & symptoms

Radiological Findings Characterstic feature
Fever Cough Hemoptysis Dyspnea Chest pain Weight loss Night sweats
High-grade Low grade Productive Dry
Acute Lung abscess + - + - - - + - -
  • Air fluid level
Malignancy

(primary lung cancer)

- + - + + - - + +
  • Coin-shaped lesion
  • Thick wall(>15mm)
  • Ground glass opacities 
  • Long H/o smoking
  • Elderly male or female
  • BAL positive for malignant cells
  • CT guided biopsy is required for confirmation and differnatiation
Pulmonary Tuberculosis + - + - + - - - +
  • Cavitations in the upper lobe of the lung
Necrotizing Pneumonia + - + + - + - -
  • Multiple cavitary lesions
  • Acute life threatening condition
  • Complication of pneumonia or lung abscess
  • Multiple organisms responsible
  • prompt treatment with antibiotics is required
  • CBC positive for causative organism
Empyema + - + - + + + - -
  • Blood culture positive for causative agent.
Bronchiectasis - - + - + - - - -
  • Linear lucencies
  • Tram tracking appearance
  • Clustered cysts
  • CT confirms the diagnosis .
Wegners granulomatosis - - + + + - - -
  • Seen mostly in female age group of 40-55 years
  • Traid of Upper , lower respiratory tract and kidney disease
  • Biopsy of involved organ confirms granulomas
Sarcoidosis + - + - + - - + +
Rheumatoid nodule - - - - - + - + -
Langerhans cell Histiocytosis - - - - - + + + -
  • Thin-walled cystic cavities
  • Exclusively afflicts smokers.
  • Musculoskeletal and skin is involved
  • Biopsy of the involved organ
Bronchiolitis obliterans - - + - + + + - -
  • Ground-glass opacities
  • Nodules.
  • Biopsy

References

  1. Erasmus JJ, Connolly JE, McAdams HP, Roggli VL (2000). "Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions". Radiographics. 20 (1): 43–58. doi:10.1148/radiographics.20.1.g00ja0343. PMID 10682770.
  2. Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK (June 2012). "Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging". Radiol Oncol. 46 (2): 106–13. doi:10.2478/v10019-012-0021-3. PMC 3472932. PMID 23077446.
  3. Maxwell RJ, Gibbons JR, O'Hara MD (January 1985). "Solitary squamous papilloma of the bronchus". Thorax. 40 (1): 68–71. PMC 459982. PMID 3969658.
  4. Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K (1998). "Solitary bronchioloalveolar adenoma of the lung". Respiration. 65 (6): 483–5. doi:10.1159/000029319. PMID 9817965.
  5. Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D (March 2017). "A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung". Cureus. 9 (3): e1069. doi:10.7759/cureus.1069. PMC 5375953. PMID 28409070.
  6. Kelley LC, Puette M, Langheinrich KA, King B (November 1994). "Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry". Vet. Pathol. 31 (6): 658–62. doi:10.1177/030098589403100605. PMID 7863581.
  7. Roth E, Smidt D (January 1970). "[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs]". Berl. Munch. Tierarztl. Wochenschr. (in German). 83 (1): 7–11. PMID 5528918.
  8. Jackman DM, Johnson BE (2005). "Small-cell lung cancer". Lancet. 366 (9494): 1385–96. doi:10.1016/S0140-6736(05)67569-1. PMID 16226617.
  9. Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson. "Chapter 13, box on morphology of adenocarcinoma". Robbins Basic Pathology (8th ed.). Philadelphia: Saunders. ISBN 1-4160-2973-7.
  10. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S; et al. (2007). "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer". Nature. 448 (7153): 561–6. doi:10.1038/nature05945. PMID 17625570.
  11. Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg
  12. Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G (January 2014). "Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology". Virchows Arch. 464 (1): 61–8. doi:10.1007/s00428-013-1501-6. PMID 24221342.
  13. Huang SY, Shen SJ, Li XY (October 2013). "Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases". World J Surg Oncol. 11: 252. doi:10.1186/1477-7819-11-252. PMC 3850921. PMID 24088577.
  14. Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S (March 2009). "Lung carcinoid tumor biology: treatment and survival". Oncol. Rep. 21 (3): 757–60. PMID 19212636.
  15. Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM (July 2013). "Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome". AJR Am J Roentgenol. 201 (1): W57–63. doi:10.2214/AJR.12.9579. PMC 3767141. PMID 23789697.
  16. Greenberg AK, Yee H, Rom WN (2002). "Preneoplastic lesions of the lung". Respir. Res. 3: 20. PMC 107849. PMID 11980589.
  17. Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP (April 2014). "Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms". Insights Imaging. 5 (2): 237–44. doi:10.1007/s13244-013-0306-0. PMC 3999366. PMID 24407922.
  18. Chaudhuri MR (1973). "Primary pulmonary cavitating carcinomas". Thorax. 28 (3): 354–66. PMC 470041. PMID 4353362.
  19. Mouroux J, Padovani B, Elkaïm D, Richelme H (1996). "Should cavitated bronchopulmonary cancers be considered a separate entity?". Ann. Thorac. Surg. 61 (2): 530–2. doi:10.1016/0003-4975(95)00973-6. PMID 8572761.
  20. Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
  21. Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
  22. Suri HS, Yi ES, Nowakowski GS, Vassallo R (2012). "Pulmonary langerhans cell histiocytosis". Orphanet J Rare Dis. 7: 16. doi:10.1186/1750-1172-7-16. PMC 3342091. PMID 22429393.